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utility estimates. Regression models (tobit, OLS, Censored least absolute deviation) 
were used to estimate speciﬁ c changes in HRQL associated with the side effects. 
RESULTS: Many participants reported more than one symptom, with ED most 
common (n = 139); reduced libido (n = 99); ejaculatory disorder (n = 98), and gyne-
comastia (n = 20). From the OLS regression EQ-5D and SQoL-3D disutilities were 
estimated for ED (−0.042; −0.075); reduced libido (−0.053; −0.047); ejaculatory dis-
order (−0.046; −0.028), and gynecomastia (−0.045; −0.037) respectively. EQ-5D and 
SQoL-3D were weakly correlated (r = 0.296). CONCLUSIONS: The condition-speciﬁ c 
and generic estimates indicate the impact of prostate-related preventative treatment 
on HRQL. While the magnitude of disutilities is similar the poor correlation between 
the two measures suggests they are measuring different aspects of HRQL. The value 
of condition-speciﬁ c versus generic methods for estimating utilities will be discussed.
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OBJECTIVES: The Sexual Function Questionnaire (SFQ-28) is a well established and 
validated self-reported screening and outcomes measure of female sexual dysfunction 
(FSD). In order to reduce patient burden and focus on symptoms of FSD, two domains 
(partner and enjoyment) have been removed to create an abbreviated version (ASFQ). 
The objective of this study was to ensure that the removal of these domains had not 
changed the psychometric properties of the measure. METHODS: Forty seven pre-
menopausal women with diagnosed female sexual arousal disorder (FSAD), primarily 
cognitive arousal difﬁ culties, completed the ASFQ, the Women’s Sexual Distress 
Questionnaire (WSDQ), an FSAD daily diary and a meaningful beneﬁ t question 
(MBQ) as part of a double-blind, placebo-controlled, 3-way crossover trial. Baseline 
data were used to assess internal consistency and convergent validity (with the FSAD 
diary). Known groups validity (comparing those with high versus low levels of distress 
on the WSDQ at end of treatment) and responsiveness of the arousal domains of ASFQ 
were also assessed. RESULTS: The ASFQ domains demonstrated excellent internal 
consistency with Cronbach’s alpha ranging from 0.73 to 0.89. All ASFQ domains 
showed excellent convergent validity with the respective items on the FSAD diary. 
Excellent known groups validity was demonstrated for the desire and arousal cognitive 
domains with those with higher distress scores showing poorer scores on these dimen-
sions of the ASFQ. Moderate effect sizes were observed in the arousal domains for 
those who indicated they had a meaningful improvement in their arousal disorder 
during the trial. CONCLUSIONS: The results conﬁ rm that the removal of two 
domains from the SFQ-28 has not impacted on its psychometric properties or respon-
siveness. The ASFQ is recommended for use in studies where patient burden needs to 
be minimized.
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OBJECTIVES: The objective of this qualitative interview study was to assess the 
content validity of the BII in a sample of men with signs and symptoms of BPH using 
concept elicitation (CE) and cognitive interviewing (CI) methods. METHODS: Fifty 
men with BPH participated in the study; 27 completed the CEs and 23 completed the 
CIs. CEs were semi-structured asking subjects to describe the BPH symptoms they 
experience and how symptoms impact their life. CIs were semi-structured, asking 
subjects to describe their 1) difﬁ culties completing the BII; 2) understanding of item 
meaning and terminology; 3) understanding of response options; and 4) ability to 
respond appropriately to the speciﬁ ed recall period. All interviews were audio recorded 
and transcribed. Data was analyzed using Atlas.ti. a saturation table was used to 
identify when no new concepts were forthcoming. Inter-rater agreement (IRA) was 
evaluated by having three coders independently dual-code 3 (11%) transcripts. Con-
sistency of coding was characterized by agreement in the identiﬁ cation of concepts, 
and agreement in assignment of codes. RESULTS: Saturation of concepts was reached 
by the completion of 21 CE interviews. High agreement on coding consistency was 
achieved at 69.4 to 89.4% for identiﬁ cation of concepts, and 87.8 to 96% for assign-
ments of codes. The BII was shown to be readily understandable and easily completed 
in a short period of time, and supported by the qualitative results as measuring the 
relevant impacts related to BPH. CONCLUSIONS: The BII shows strong evidence of 
content validity and provides an assessment of disease-related, clinically meaningful 
impacts of BPH symptoms and treatment outcomes in BPH studies.
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OBJECTIVES: Translation and linguistic validation of patient reported outcomes 
(PRO) measures is an essential component of research methodology in preparation 
for multinational clinical trials. The Injection Pen Assessment Questionnaire (IPAQ) 
is a dyadic (parent and child together) or self-report of ease of use and preference tool 
that allows objective and normative comparisons across and between injection pens 
used to administer human growth hormone (hGH). The purpose of this work was to 
translate and linguistically validate the IPAQ, which was developed in English in the 
United States, for use in 7 countries: Czech Republic, Germany, The Netherlands, 
Slovakia, Sweden, Turkey and United Kingdom. METHODS: The IPAQ was trans-
lated according to industry standard methodology. Five parent-child dyads (children 
8 to 18 years old) per country completed the respective translated questionnaire and 
participated in a cognitive interview. Interviews were conducted using a standardized 
guide to assess the relevance, understandability, and appropriateness of the wording 
of the translations. Qualitative analyses were performed to ensure equivalence and 
that the content validity of the IPAQ was maintained across language versions. 
RESULTS: The study sample consisted of 35 parent-child dyads who use injection 
devices to administer hGH (42.8% male). Mean age of the children was 12 years. The 
sample consisted of patients who speak 7 languages collectively. All IPAQ items were 
well understood and proved relevant to the patients in this sample. Of interest, terms 
such as, “cartridge”, “needle guard” and “injecting the medicine” were understood 
similarly by participants across countries. CONCLUSIONS: The results indicate the 
IPAQ translations were conceptually equivalent to the English source version and 
easily understood by the target population in all countries. We consider these transla-
tions acceptable for PRO assessment in international research, clinical practice and 
clinical trials.
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OBJECTIVES: To elaborate and validate a questionnaire on patient satisfaction with 
the follitropin alfa preﬁ lled pen, compared with previously used injectable gonadotro-
pins, in women undergoing ovarian stimulation. METHODS: VENUsf questionnaire 
with 14 items was constructed after a four-stage process (concept identiﬁ cation and 
item generation; item review by an expert on female infertility; patients interview; and 
editing of questionnaire according to interviews results) in which both experts on 
health outcomes research and fertility professionals and patients were involved. a 
post-authorization observational study (non-randomised patients, national setting) 
was undergone in order to validate the questionnaire. After assessing sample adequacy 
(Kaiser-Meyer-Olkin index and Bartlett’s test of sphericity), Rasch analysis (inﬁ t and 
outﬁ t statistics) provided a reduced version of the questionnaire. Its psychometric 
properties were assessed: feasibility (omitted response and time to fulﬁ l it), variability 
(ﬂ oor and ceiling effects), validity (factor analysis and nonparametric tests) and reli-
ability (Cronbach’s alpha). RESULTS: Initial questionnaire (14 items and 6 additional 
questions) was answered by 91.1% of sample (n = 107) in an average of 5.04 minutes 
(SD = 3.3). Statistical correlation was observed between scores from two dimensions 
of questionnaire and overall treatment satisfaction, as well as variables Number of 
previous treatments, Time since last treatment and Minutes required to prepare pen. 
Rasch analyses yield 9 items in the ﬁ nal version of the questionnaire. This process was 
conﬁ rmed by sample adequacy (KMO = 0.72, statistically signiﬁ cant value of Bartlett’s 
test of sphericity) and reliability parameters (Cronbach’s alpha = 0.78). CONCLU-
SIONS: The reduced version of the questionnaire VENUsf a feasible, valid and reliable 
tool for assessing patient satifaction with follitropin alfa preﬁ lled pen in women 
undergoing ovarian stimulation.
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OBJECTIVES: To assess the perceptions of the general public in Malaysia about the 
importance of drug labeling. METHODS: A cross sectional study using pre-validated 
questionnaire was undertaken with a convenient sample of general public in the State 
of Penang, Malaysia. All data was analyzed using SPSS for Windows version 12.0. 
Inferential statistics were used whenever appropriate at alpha value of 0.05 or less 
considered signiﬁ cant. RESULTS: A total of 365 respondents had participated in the 
survey. Majority of them agreed that drug labeling is important to any person dispens-
ing medicines (74.8%), caretakers (76.26%), health care professionals (77.8%) and 
patients (80.6%). Besides, they believed that it is important to ensure all drug labels 
are not vaguely claimed to improve quality of life (54.2%). Majority of respondents 
agreed that incorrect dosage instructions on the drug label would result in worsening 
the quality of life (73.2%). Majority of respondents (58.4%) believed that drug label-
ing is highly important to ensure safe and effective drug use. Majority also expected 
that all drug products and controlled medicines should be labeled with product name 
(97.5%), active ingredients (78%), date of manufacture and expiry (87%), and dosage 
